Page 1 of Clinical Trials for HIV-1, 1410 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication
Last Updated: January 25, 2010
Condition(s): HIV-1; HIV Infections
2
Active, not recruiting
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
Last Updated: December 3, 2010
Condition(s): HIV-1 Infections; HIV Infections
3
Active, not recruiting
A Study to Assess the Efficacy of Raltegravir, Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145)
Last Updated: April 15, 2011
Condition(s): HIV-1 Infection
4
Recruiting
Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation
Last Updated: July 22, 2010
Condition(s): HIV-1
5
Recruiting
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
Last Updated: May 10, 2012
Condition(s): HIV-1
6
Completed
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults
Last Updated: May 16, 2012
Condition(s): HIV Infections
7
Recruiting
KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
Last Updated: February 2, 2012
Condition(s): Antiretroviral Therapy in HIV-1 Infected Children
8
Completed
A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)
Last Updated: June 9, 2011
Condition(s): HIV-1; HIV Infections
9
Completed
A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.
Last Updated: June 23, 2005
Condition(s): HIV Infections
10
Completed
A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)
Last Updated: May 16, 2012
Condition(s): HIV Infections
11
Recruiting
Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
Last Updated: March 31, 2011
Condition(s): Acquired Immunodeficiency Syndrome
12
Suspended
Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
Last Updated: May 17, 2012
Condition(s): HIV Infections
13
Completed
A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers
Last Updated: May 16, 2012
Condition(s): HIV Infections; HIV Seronegativity
14
Completed
A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults
Last Updated: May 23, 2012
Condition(s): HIV Infections
15
Completed
A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine
Last Updated: July 7, 2009
Condition(s): HIV-1 Infection
16
Completed
A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)
Last Updated: June 23, 2005
Condition(s): HIV Infections
17
Terminated
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy
Last Updated: July 29, 2010
Condition(s): HIV-1 Infection
18
Completed
A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects
Last Updated: June 23, 2005
Condition(s): HIV Infections
19
Not yet recruiting
Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors
Last Updated: March 30, 2012
Condition(s): HIV-1 Infection
20
Recruiting
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Last Updated: September 2, 2011
Condition(s): HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=HIV-1

Page 1 of Clinical Trials for HIV-1, 1410 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About